 |
The Journal of Neuroscience, January 26, 2005, 25(4):896-905; doi:10.1523/JNEUROSCI.3258-04.2005
Previous Article | Next Article 
Behavioral/Systems/Cognitive
The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling
Samir Haj-Dahmane and
Roh-Yu Shen
Research Institute on Addictions, University at Buffalo, State University of New York, Buffalo, New York 14203
The wake-promoting neuropeptides orexins (hypocretins) play a crucial role in controlling neuronal excitability and synaptic transmission in the CNS. In this study, using whole-cell patch-clamp recordings in an acute dorsal raphe nucleus (DRN) slice preparation, we report that orexin B (Orx-B) depresses the evoked glutamate-mediated synaptic currents in DRN 5-HT neurons. The Orx-B-induced depression is accompanied by an increase in the paired-pulse ratio and the coefficient of variance, suggesting a presynaptic site of action. Orx-B also reduces the frequency but not the amplitude of miniature EPSCs, indicating that depression of glutamatergic transmission is mediated by a decrease in glutamate release. Surprisingly, the Orx-B-induced inhibition of glutamatergic transmission is abolished by postsynaptic inhibition of G-protein signaling with GDP S, suggesting that this effect is signaled by postsynaptic orexin receptors and expressed presynaptically, presumably through a retrograde messenger. Interestingly, the Orx-B-induced depression of glutamate release is mimicked and occluded by the cannabinoid receptor agonist WIN 55,212-2, and is abolished by the CB1 cannabinoid receptor antagonist AM 251. These results imply that the Orx-B-induced depression of glutamatergic transmission to DRN 5-HT neurons is mediated by retrograde endocannabinoid release. Examination of downstream signaling pathways involved in this response indicates that the effect of Orx-B requires the activation of phospholipase C and DAG lipase enzymatic pathways but not a rise in postsynaptic intracellular calcium. Therefore, our findings reveal a previously unsuspected mechanism by which postsynaptic orexin receptors can modulate glutamatergic synaptic transmission to DRN 5-HT neurons.
Key words: raphe; serotonin; orexin; cannabinoid; glutamate; synaptic transmission
Received Aug 9, 2004;
revised December 8, 2004;
accepted December 8, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
F. R. Bambico, N. Katz, G. Debonnel, and G. Gobbi
Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex
J. Neurosci.,
October 24, 2007;
27(43):
11700 - 11711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, M. Watanabe, and M. Kano
Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release
J. Physiol.,
October 15, 2007;
584(2):
373 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Beique, M. Imad, L. Mladenovic, J. A. Gingrich, and R. Andrade
Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex
PNAS,
June 5, 2007;
104(23):
9870 - 9875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano
Endocannabinoids and Synaptic Function in the CNS
Neuroscientist,
April 1, 2007;
13(2):
127 - 137.
[Abstract]
[PDF]
|
 |
|
|